Drug Patent Exclusivity: What the USPTO Study Actually Tells IP Teams, Portfolio Managers, and Generic Challengers

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/ Executive Summary and Key Findings The USPTO’s Drug Patent and Exclusivity Study, produced … Continue reading Drug Patent Exclusivity: What the USPTO Study Actually Tells IP Teams, Portfolio Managers, and Generic Challengers